Instructions for Use (IFU) provide directions necessary for users to safely and effectively use a medical device, including indications, contraindications, warnings, precautions, and operating instructions. IFU content typically covers intended purpose, indications, contraindications, warnings, precautions, set-up, operating steps, maintenance, cleaning and disposal. Requirements are set in 21 CFR Part 801 in the US and Annex I, Chapter III of the EU MDR and IVDR. Because users act on the IFU, it is also a risk control: usability engineering under IEC 62366-1 often relies on it, and its effectiveness should be validated with representative users.

Why it matters

IFU content is regulated by FDA labeling requirements (21 CFR Part 801) and EU MDR Annex I. Cybersecurity-relevant information must increasingly be included for connected devices.

Common pitfalls

•Not all required elements, such as warnings, contraindications, or cybersecurity information, are included in the IFU.
•The IFU is not written in clear, unambiguous language readily understood by the intended user population.
•The IFU is not adequately maintained and updated throughout the device's lifecycle to reflect changes or new safety information.
•Failure to translate the IFU accurately for all markets where the device is sold, impacting user comprehension and safety.
•Treating the IFU solely as a legal document rather than a critical tool for user education and risk mitigation.

Sources

21 CFR Part 801 · eCFR
FDA - Medical Devices · FDA
European Commission - Medical Devices · European Commission

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.